GammaTile news

Brain tumors are one of the most devastating consequences of cancer’s spread—hard to treat and highly deadly. Scientists have found that using a radioactive implant precisely where a tumor was removed in the brain can help patients get their cancer treated more quickly and in many cases, live longer.

A radiation therapy implant demonstrated significantly improved surgical bed control and longer overall survival compared to standard stereotactic radiotherapy (SRT) after resection of large brain metastases, according to a phase 3 trial.

Several late-phase studies presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago point to potential shifts in how cancer is treated and detected.

The first trial to directly compare implanted tile-based radiation to standard external beam radiation for the treatment of brain metastases shows that starting radiation immediately after surgery improves outcomes. Tile-based radiation prolonged the time to recurrence without significantly increasing treatment-related health problems. In addition, the tiles improved overall survival, possibly because patients can restart systemic therapy sooner, the authors suggest. 

A small radiation-emitting tile implanted where a brain ​tumor had been achieves better outcomes than traditional radiation treatments, researchers reported at ASCO.

A collagen implant that releases radiation after brain tumor surgery reduced cancer recurrence and increased overall survival, according to results presented at ASCO’s annual meeting.

Intracranial brachytherapy has become an increasingly prominent part of the neurosurgical oncologist’s toolbox. In this episode, we will explore some of the indications, active areas of exploration, and current controversies surrounding its use. 

Guest faculty: Wenya Linda Bi and Phillip Devlin
Co-hosts: W. Christopher Newman and Seth Oliveria

In the early 2010s, five individuals with medical backgrounds in radiation oncology and neurosurgery joined forces to develop GammaTile, a brachytherapy technology designed to deliver a precisely controlled dose of radiation to the tumor cavity directly after resection surgery with minimal impact on surrounding healthy tissue.

In this episode of Med Tech Gurus, Dr. Michael Garcia breaks down how GammaTile works, why earlier radiation matters, and the compelling clinical evidence demonstrating improved patient outcomes — including meaningful reductions in recurrence risk without added safety concerns. 

Ascension St. Vincent's Riverside has successfully treated its first patient with GammaTile® Therapy—a major step forward in the fight against brain tumors.

“GammaTile is a game changer in surgical care for our patients with brain tumors,” said Dr. Aristotelis Filippidis, Neurosurgeon at St. Vincent's. “The highly targeted therapy at the tumor cavity after resection, the area that is needed most to delay recurrence, is delivered while patients go about their everyday lives, reducing their hardship after surgery.”

A new approach to fighting brain tumors is showing promising results by targeting cancer cells with a tiny radiation-emitting implant.

This episode of the ACRO Podcast is sponsored by GT Medical Technologies:

In the latest episode of the ACRO Podcast, our host ACRO President-elect Brian Lally, MD speaks with Tugce Kutuk, MD, a radiation oncology resident at Ohio State University about GammaTile® Brachytherapy. GammaTile® is surgically targeted radiation therapy that has been FDA-cleared for treating operable brain tumors. 

Dr. Jay McCracken and The Game on Glio Podcast join Hope Rises for this Daytime Buffalo segment to talk about their innovative and lifesaving work for those fighting brain cancer, as well as critical advocacy efforts. In honor of Brain Cancer Awareness Month in May, there is hope in the form of treatments like GammaTile.

D. Jay McCracken, MD, FAANS, is a Neurosurgical Oncologist and the Medical Director of the Stereotactic Radiosurgery Program at Piedmont Hospital in Atlanta, GA.

With GammaTile, we can do an excellent job of delivering a very high dose of radiation specifically to the problem areas while sparing healthy brain tissue that is only millimeters away.” – Imran Mohiuddin, MD, PhD, Radiation Oncologist, AdventHealth Orlando.

GammaTile is the first and only tile-based radiation therapy for the treatment of operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was recently named as Florida’s first GammaTile Center of Excellence.

Dr. D. Jay McCracken, Neurosurgeon and Medical Director of the Stereotactic Radiosurgery Program at Piedmont Atlanta Hospital, is featured in this news segment, explaining how GammaTile radiation therapy can help patients with operable brain tumors.